BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tapper EB, Asrani SK. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. J Hepatol. 2020;73:441-445. [PMID: 32298769 DOI: 10.1016/j.jhep.2020.04.005] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 35.0] [Reference Citation Analysis]
Number Citing Articles
1 Shaheen AA, Kong K, Ma C, Doktorchik C, Coffin CS, Swain MG, Burak KW, Congly SE, Lee SS, Sadler M, Borman M, Abraldes JG. Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01143-5. [PMID: 34715379 DOI: 10.1016/j.cgh.2021.10.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Pawlotsky JM. COVID-19 and the liver-related deaths to come. Nat Rev Gastroenterol Hepatol. 2020;17:523-525. [PMID: 32528138 DOI: 10.1038/s41575-020-0328-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
3 Singh AD. Telemedicine Workflow and Platform Options: What Would Work Well for Your Practice? Clinical Liver Disease. [DOI: 10.1002/cld.1173] [Reference Citation Analysis]
4 Abdelkafi I, Loukil S, Romdhane Y. Economic Uncertainty During COVID-19 Pandemic in Latin America and Asia. J Knowl Econ. [DOI: 10.1007/s13132-021-00889-5] [Reference Citation Analysis]
5 Serper M, Shaked A, Olthoff KM, Hoteit M, Appolo B, Reddy KR. A local response to COVID-19 for advanced liver disease: Current model of care, challenges and opportunities. J Hepatol 2020;73:708-9. [PMID: 32450089 DOI: 10.1016/j.jhep.2020.05.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Keller M, Sun J, Mutebi C, Shah P, Levine D, Aryal S, Iacono A, Timofte I, Mathew J, Varghese A, Giner C, Agbor-enoh S. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care. The Journal of Heart and Lung Transplantation 2021. [DOI: 10.1016/j.healun.2021.12.009] [Reference Citation Analysis]
7 Russo FP, Izzy M, Rammohan A, Kirchner VA, Di Maira T, Belli LS, Berg T, Berenguer MC, Polak WG. Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS). J Hepatol 2021:S0168-8278(21)02107-3. [PMID: 34653592 DOI: 10.1016/j.jhep.2021.09.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
8 Hutchison AL, Pillai A. The effect of COVID-19 on liver transplantation: impact, practice patterns, therapeutics, and next steps. Curr Opin Organ Transplant 2021;26:339-45. [PMID: 33938470 DOI: 10.1097/MOT.0000000000000883] [Reference Citation Analysis]
9 Ponziani FR, Aghemo A, Cabibbo G, Masarone M, Montagnese S, Petta S, Russo FP, Lai Q; AISF COVID-19 survey group. Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey. Liver Int 2021;41:2228-32. [PMID: 34219343 DOI: 10.1111/liv.14998] [Reference Citation Analysis]
10 Sloan M, Gordon C, Harwood R, Lever E, Wincup C, Bosley M, Brimicombe J, Pilling M, Sutton S, Holloway L, D'Cruz D. The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study. Rheumatol Adv Pract 2021;5:rkaa072. [PMID: 33604501 DOI: 10.1093/rap/rkaa072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ge J, Pletcher MJ, Lai JC; N3C Consortium. Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study. medRxiv 2021:2021. [PMID: 34127981 DOI: 10.1101/2021.06.03.21258312] [Reference Citation Analysis]
12 Hamid S, Alvares da Silva MR, Burak KW, Chen T, Drenth JPH, Esmat G, Gaspar R, LaBrecque D, Lee A, Macedo G, McMahon B, Ning Q, Reau N, Sonderup M, van Leeuwen DJ, Armstrong D, Yurdaydin C. WGO Guidance for the Care of Patients With COVID-19 and Liver Disease. J Clin Gastroenterol. 2021;55:1-11. [PMID: 33230011 DOI: 10.1097/mcg.0000000000001459] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
13 Sagnelli C, Macera M, Camaioni C, Salvati A, Coppola N, Sagnelli E. SARS-CoV-2 infection: a hurricane that does not ignore chronic hepatitis. Infection 2022. [PMID: 35316530 DOI: 10.1007/s15010-022-01804-z] [Reference Citation Analysis]
14 Linck PA, Garnier C, Depetiteville MP, MacGrogan G, Mathoulin-Pélissier S, Quénel-Tueux N, Charitansky H, Boisserie-Lacroix M, Chamming's F. Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre. Eur Radiol 2021. [PMID: 34647179 DOI: 10.1007/s00330-021-08264-3] [Reference Citation Analysis]
15 Elnaggar M, Abomhya A, Elkhattib I, Dawoud N, Doshi R. COVID-19 and liver diseases, what we know so far. World J Clin Cases 2022; 10(13): 3969-3980 [DOI: 10.12998/wjcc.v10.i13.3969] [Reference Citation Analysis]
16 Kapuria D, Bollipo S, Rabiee A, Ben-Yakov G, Kumar G, Siau K, Lee HW, Congly S, Turnes J, Dhanasekaran R, Lui RN; Global Online Alliance for Liver Studies (GOAL). Roadmap to resuming care for liver diseases after coronavirus disease-2019. J Gastroenterol Hepatol 2021;36:885-92. [PMID: 32656794 DOI: 10.1111/jgh.15178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Manship T, Brennan PN, Campbell I, Campbell S, Clouston T, Dillon JF, Forrest E, Fraser A, Goh TL, Johnston M, Khan MI, Livie V, Murray IA, Saunders J, Troland D, Simpson KJ. Effect of COVID-19 on presentations of decompensated liver disease in Scotland. BMJ Open Gastroenterol 2022;9:e000795. [PMID: 34992071 DOI: 10.1136/bmjgast-2021-000795] [Reference Citation Analysis]
18 Ismond KP, Eslamparast T, Farhat K, Stickland M, Spence JC, Bailey RJ, Abraldes JG, Spiers JA, Tandon P. Assessing Patient Proficiency with Internet-Connected Technology and Their Preferences for E-Health in Cirrhosis. J Med Syst 2021;45:72. [PMID: 34091771 DOI: 10.1007/s10916-021-01746-3] [Reference Citation Analysis]
19 Kumar M, Iyer SS. ASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing. Expert Rev Mol Diagn 2021;21:349-62. [PMID: 33706663 DOI: 10.1080/14737159.2021.1902311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Taylor J, Wright A, Summers M. The pandemic silver lining: preparing osteopathic learners to address healthcare needs using telehealth. J Osteopath Med 2021. [PMID: 34674408 DOI: 10.1515/jom-2021-0162] [Reference Citation Analysis]
21 Antonacci CL, Omari AM, Zaifman J, Baig AF, Sommi CP, Medvedev G, Savoie FH, Sethi PM, Klein GR, Koerner JD, Alberta FG. Differences in Patient and Physician Perceptions of Urgency for Musculoskeletal Conditions During the COVID-19 Pandemic. Orthopedics 2021;44:e534-8. [PMID: 34292807 DOI: 10.3928/01477447-20210618-13] [Reference Citation Analysis]
22 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
23 Julien J, Ayer T, Tapper EB, Barbosa C, Dowd WN, Chhatwal J. Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: A modeling study. Hepatology 2022;75:1480-90. [PMID: 34878683 DOI: 10.1002/hep.32272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
24 Ridruejo E, Soza A. The liver in times of COVID-19: What hepatologists should know. Ann Hepatol. 2020;19:353-358. [PMID: 32425991 DOI: 10.1016/j.aohep.2020.05.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
25 Yeo YH, Hwang J, Jeong D, Dang N, Kam LY, Henry L, Park H, Cheung R, Nguyen MH. Surveillance of patients with cirrhosis remains suboptimal in the United States. J Hepatol 2021:S0168-8278(21)00307-X. [PMID: 33965477 DOI: 10.1016/j.jhep.2021.04.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Vaishnav M, Elhence A, Biswas S, Pathak P, Anand A, Sheikh S, Singh V, Maitra S, Goel A, Shalimar. The Outcome after Hospital Discharge in Cirrhosis is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis. J Clin Exp Hepatol 2021. [PMID: 34840484 DOI: 10.1016/j.jceh.2021.11.009] [Reference Citation Analysis]
27 Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med. 2020;77:18-24. [PMID: 32507608 DOI: 10.1016/j.ejim.2020.05.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
28 Arrese M. Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology. Ann Hepatol 2020;19:339-40. [PMID: 32482463 DOI: 10.1016/j.aohep.2020.05.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Eshraghian A, Taghavi A, Nikeghbalian S, Malek-Hosseini SA. Reduced rate of hospital admissions for liver-related morbidities during the initial COVID-19 outbreak. Lancet Gastroenterol Hepatol 2020;5:803-4. [PMID: 32615070 DOI: 10.1016/S2468-1253(20)30207-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Zampino R, Vitrone M, Spiezia S, Albisinni R, Durante-Mangoni E. Remote Outpatient Management During COVID-19 Lockdown: Patient-Derived Quality Assessment. Qual Manag Health Care 2021;30:76-7. [PMID: 33306652 DOI: 10.1097/QMH.0000000000000296] [Reference Citation Analysis]
31 Feldman J, Szerencsy A, Mann D, Austrian J, Kothari U, Heo H, Barzideh S, Hickey M, Snapp C, Aminian R, Jones L, Testa P. Giving Your Electronic Health Record a Checkup After COVID-19: A Practical Framework for Reviewing Clinical Decision Support in Light of the Telemedicine Expansion. JMIR Med Inform 2021;9:e21712. [PMID: 33400683 DOI: 10.2196/21712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Gualano MR, Corradi A, Voglino G, Bert F, Siliquini R. Beyond COVID-19: a cross-sectional study in Italy exploring the covid collateral impacts on healthcare services. Health Policy 2021;125:869-76. [PMID: 33840478 DOI: 10.1016/j.healthpol.2021.03.005] [Reference Citation Analysis]
33 Fix OK, Serper M. Telemedicine and Telehepatology During the COVID-19 Pandemic. Clin Liver Dis (Hoboken) 2020;15:187-90. [PMID: 32537134 DOI: 10.1002/cld.971] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
34 Morales-Arraez D, Hernández-Bustabad A, Medina-Alonso MJ, Santiago-Gutiérrez LG, García-Gil S, Diaz-Flores F, Pérez-Pérez V, Nazco J, Fernandez de Rota Martin P, Gutiérrez F, Hernández-Guerra M. Telemedicine and decentralized hepatitis C treatment as a strategy to enhance retention in care among people attending drug treatment centres. Int J Drug Policy 2021;94:103235. [PMID: 33838399 DOI: 10.1016/j.drugpo.2021.103235] [Reference Citation Analysis]
35 Afaghi P, Lapolla MA, Ghandi K. Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients. Heliyon 2021;7:e06454. [PMID: 33748501 DOI: 10.1016/j.heliyon.2021.e06454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Awadasseid A, Wu Y, Tanaka Y, Zhang W. Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines. Biomed Pharmacother 2021;137:111330. [PMID: 33550043 DOI: 10.1016/j.biopha.2021.111330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Mehta N, Parikh ND, Kelley RK, Hameed B, Singal AG. Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic. Clin Gastroenterol Hepatol 2021;19:1520-30. [PMID: 32652308 DOI: 10.1016/j.cgh.2020.06.072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
38 Boettler T, Marjot T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Jalan R, Moreau R, Cornberg M, Berg T. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 mo of the pandemic. JHEP Rep. 2020;2:100169. [PMID: 32835190 DOI: 10.1016/j.jhepr.2020.100169] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 21.0] [Reference Citation Analysis]
39 Jaffe A, Schilsky ML, Deshpande R, Batra R. Liver Transplantation in the Time of COVID19: Barriers and Ethical considerations for Management and Next Steps. Hepatol Commun. 2020;. [PMID: 32838103 DOI: 10.1002/hep4.1568] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
40 Scaldaferri F, Ianiro G, Privitera G, Lopetuso LR, Vetrone LM, Petito V, Pugliese D, Neri M, Cammarota G, Ringel Y, Costamagna G, Gasbarrini A, Boskoski I, Armuzzi A. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications. Inflamm Bowel Dis. 2020;26:1306-1314. [PMID: 32720978 DOI: 10.1093/ibd/izaa181] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
41 Mahmud N, Kaplan DE, Goldberg DS, Taddei TH, Serper M. Changes in Hepatocellular Carcinoma Surveillance and Risk Factors for Noncompletion in the Veterans Health Administration Cohort During the Coronavirus Disease 2019 Pandemic. Gastroenterology 2021;160:2162-2164.e3. [PMID: 33434604 DOI: 10.1053/j.gastro.2021.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Tan EX, Quek WL, Suryadi, Chahed H, Iyer SG, Jeyaraj PR, Lee GH, Chan A, Cheng S, Hoe J, Tan EK, Chew LY, Fung J, Chen M, Muthiah MD, Huang DQ. Impact of COVID-19 on Liver Transplantation in Hong Kong and Singapore: A Modelling Study. Lancet Reg Health West Pac 2021;16:100262. [PMID: 34514452 DOI: 10.1016/j.lanwpc.2021.100262] [Reference Citation Analysis]
43 Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
44 Bitar H, Alismail S. The role of eHealth, telehealth, and telemedicine for chronic disease patients during COVID-19 pandemic: A rapid systematic review. Digit Health 2021;7:20552076211009396. [PMID: 33959378 DOI: 10.1177/20552076211009396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Brahmania M, Congly S, Jayakumar S, Coffin CS, Burak KW, Feld JJ. An update from the Canadian Association for the Study of the Liver on the management of liver disease during the COVID-19 pandemic. CanLivJ 2020;3:309-21. [DOI: 10.3138/canlivj-2020-0013] [Reference Citation Analysis]
46 Higuera-de la Tijera F, Servín-Caamaño A, Reyes-Herrera D, Flores-López A, Robiou-Vivero EJA, Martínez-Rivera F, Galindo-Hernández V, Chapa-Azuela O, Chávez-Morales A, Rosales-Salyano VH. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19. Liver Res 2021;5:21-7. [PMID: 33520337 DOI: 10.1016/j.livres.2021.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
47 Ramkissoon R, Wang XJ. The Impact of COVID-19 in Gastroenterology and Hepatology. J Clin Gastroenterol 2021;55:757-65. [PMID: 34420001 DOI: 10.1097/MCG.0000000000001600] [Reference Citation Analysis]
48 Chan SL, Kudo M. Impacts of COVID-19 on Liver Cancers: During and after the Pandemic. Liver Cancer. 2020;9:491-502. [PMID: 33078127 DOI: 10.1159/000510765] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
49 Guarino M, Cossiga V, Fiorentino A, Pontillo G, Morisco F. Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study. J Med Internet Res 2020;22:e20874. [PMID: 32896833 DOI: 10.2196/20874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
50 Moghe A, Yakovchenko V, Morgan T, McCurdy H, Scott D, Rozenberg-Ben-Dror K, Rogal S. Strategies to Improve Delivery of Cirrhosis Care. Curr Treat Options Gastroenterol 2021;:1-11. [PMID: 34054289 DOI: 10.1007/s11938-021-00345-y] [Reference Citation Analysis]
51 Pairawan SS, Olmedo Temich L, de Armas S, Folkerts A, Solomon N, Cora C, Ramalingam K, Lum SS. Recovery of Screening Mammogram Cancellations During COVID-19. Am Surg 2021;87:1651-5. [PMID: 34628958 DOI: 10.1177/00031348211051695] [Reference Citation Analysis]
52 Crespo J, Fernández Carrillo C, Iruzubieta P, Hernández-Conde M, Rasines L, Jorquera F, Albillos A, Bañares R, Mora P, Fernández Vázquez I, Hernández-Guerra M, Turnes J, Calleja JL; COVID-19 SEPD/AEEH Group. Massive impact of coronavirus disease 2019 pandemic on gastroenterology and hepatology departments and doctors in Spain. J Gastroenterol Hepatol 2021;36:1627-33. [PMID: 33184937 DOI: 10.1111/jgh.15340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
53 Moon AM, Curtis B, Mandrekar P, Singal AK, Verna EC, Fix OK. Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation. Hepatol Commun 2021. [PMID: 34222743 DOI: 10.1002/hep4.1747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Jazieh AR, Chan SL, Curigliano G, Dickson N, Eaton V, Garcia-Foncillas J, Gilmore T, Horn L, Kerr DJ, Lee J, Mathias C, Nogueira-Rodrigues A, Pierce L, Rogado A, Schilsky RL, Soria JC, Warner JL, Yoshida K. Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars. JCO Glob Oncol 2020;6:1461-71. [PMID: 32997537 DOI: 10.1200/GO.20.00423] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
55 Vitale G, Gitto S, Marra F, Morelli MC. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic. Intern Emerg Med 2021. [PMID: 34245423 DOI: 10.1007/s11739-021-02801-0] [Reference Citation Analysis]
56 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Atherly A, Van Den Broek-Altenburg E, Hart V, Gleason K, Carney J. Consumer Reported Care Deferrals Due to the COVID-19 Pandemic, and the Role and Potential of Telemedicine: Cross-Sectional Analysis. JMIR Public Health Surveill 2020;6:e21607. [PMID: 32833661 DOI: 10.2196/21607] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
58 Tapper EB, Parikh ND. The Future of Quality Improvement for Cirrhosis. Liver Transpl 2021. [PMID: 33887806 DOI: 10.1002/lt.26079] [Reference Citation Analysis]
59 Brenner H, Holleczek B, Schöttker B. Vitamin D Insufficiency and Deficiency and Mortality from Respiratory Diseases in a Cohort of Older Adults: Potential for Limiting the Death Toll during and beyond the COVID-19 Pandemic? Nutrients 2020;12:E2488. [PMID: 32824839 DOI: 10.3390/nu12082488] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
60 Zhan GF, Wang Y, Yang N, Luo AL, Li SY. Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms. World J Gastroenterol 2021; 27(7): 561-575 [PMID: 33642829 DOI: 10.3748/wjg.v27.i7.561] [Reference Citation Analysis]
61 Hassan SS, Basu P, Redwan EM, Lundstrom K, Choudhury PP, Serrano-Aroca A, Azad GK, Aljabali AAA, Palu G, El-Aziz TMA, Barh D, Uhal BD, Adadi P, Takayama K, Bazan NG, Tambuwala M, Lal A, Chauhan G, Baetas-da-Cruz W, Sherchan SP, Uversky VN. Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution. Environ Res 2021;:112092. [PMID: 34562480 DOI: 10.1016/j.envres.2021.112092] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Téllez L, Martín Mateos RM. COVID-19 and liver disease: An update. Gastroenterol Hepatol 2020;43:472-80. [PMID: 32727662 DOI: 10.1016/j.gastrohep.2020.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
63 Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers 2021;7:6. [PMID: 33479224 DOI: 10.1038/s41572-020-00240-3] [Cited by in Crossref: 96] [Cited by in F6Publishing: 108] [Article Influence: 96.0] [Reference Citation Analysis]
64 Santambrogio R, Farina G, D'Alessandro V, Iacob G, Gemma M, Zappa MA. Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma. J Laparoendosc Adv Surg Tech A. 2021;31:266-272. [PMID: 32810426 DOI: 10.1089/lap.2020.0559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Höner Zu Siederdissen C, Schultalbers M, Wübbolding M, Lechte GS, Laser H, Cornberg M, Wedemeyer H, Maasoumy B. Impact of the COVID-19 pandemic on patients with liver cirrhosis-the experience of a tertiary center in Germany. Z Gastroenterol 2021;59:954-60. [PMID: 34507374 DOI: 10.1055/a-1540-7726] [Reference Citation Analysis]
66 Temgoua MN, Endomba FT, Nkeck JR, Kenfack GU, Tochie JN, Essouma M. Coronavirus Disease 2019 (COVID-19) as a Multi-Systemic Disease and its Impact in Low- and Middle-Income Countries (LMICs). SN Compr Clin Med 2020;:1-11. [PMID: 32838173 DOI: 10.1007/s42399-020-00417-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
67 Ahn S, Kim S, Koh K. Associations of the COVID-19 pandemic with older individuals' healthcare utilization and self-reported health status: a longitudinal analysis from Singapore. BMC Health Serv Res 2022;22:66. [PMID: 35031040 DOI: 10.1186/s12913-021-07446-5] [Reference Citation Analysis]
68 Tapper EB, Kenney B, Nikirk S, Levine DA, Waljee AK. Animal Naming Test Is Associated With Poor Patient-Reported Outcomes and Frailty in People With and Without Cirrhosis: A Prospective Cohort Study. Clin Transl Gastroenterol 2022. [PMID: 35080516 DOI: 10.14309/ctg.0000000000000447] [Reference Citation Analysis]
69 Cabibbo G, Rizzo GEM, Stornello C, Craxì A. SARS-CoV-2 infection in patients with a normal or abnormal liver. J Viral Hepat 2021;28:4-11. [PMID: 33190321 DOI: 10.1111/jvh.13440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
70 Cheema S, Ameduri M, Abraham A, Doraiswamy S, Mamtani R. The COVID-19 pandemic: the public health reality. Epidemiol Infect 2020;148:e223. [PMID: 32958089 DOI: 10.1017/S0950268820002216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]
72 Skladany L, Koller T, Adamcova Selcanova S, Vnencakova J, Jancekova D, Durajova V, Laffers L, Svac J, Janickova K, Palkovič M, Kohout P, Golubnitschaja O. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J 2021;:1-14. [PMID: 33680218 DOI: 10.1007/s13167-021-00231-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
73 Da BL, Im GY, Schiano TD. Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease. Hepatology 2020;72:1102-8. [PMID: 32369624 DOI: 10.1002/hep.31307] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 47.0] [Reference Citation Analysis]
74 Tacke F, Cornberg M, Sterneck M, Trebicka J, Settmacher U, Bechstein WO, Berg T; Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), vertreten durch Frank Tacke, Markus Cornberg, Martina Sterneck, Jonel Trebicka, Thomas Berg., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV), vertreten durch Wolf Bechstein., Deutsche Transplantationsgesellschaft (DTG), vertreten durch Utz Settmacher., Die Leitlinie wird von der Deutschen Gesellschaft für Pneumologie (DGP) unterstützt. S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie – AWMF-Register Nr. 021-031 – Stand: 07.01.21. Z Gastroenterol 2021;59:345-59. [PMID: 33845500 DOI: 10.1055/a-1372-5595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Louissaint J, Gibbs JT, Lok AS, Tapper EB. Strategies to Improve Video Visit Use in Persons With Liver Disease. Gastroenterology 2021:S0016-5085(21)03184-X. [PMID: 34197830 DOI: 10.1053/j.gastro.2021.06.070] [Reference Citation Analysis]
76 Vallamkondu J, John A, Wani WY, Ramadevi SP, Jella KK, Reddy PH, Kandimalla R. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets. Biochim Biophys Acta Mol Basis Dis 2020;1866:165889. [PMID: 32603829 DOI: 10.1016/j.bbadis.2020.165889] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
77 Ge J, Pletcher MJ, Lai JC; N3C Consortium. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study. Gastroenterology 2021:S0016-5085(21)03244-3. [PMID: 34284037 DOI: 10.1053/j.gastro.2021.07.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Wegermann K, Wilder JM, Parish A, Niedzwiecki D, Gellad ZF, Muir AJ, Patel YA. Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19. Dig Dis Sci 2021. [PMID: 33507442 DOI: 10.1007/s10620-021-06842-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
79 Kayser MZ, Valtin C, Greer M, Karow B, Fuge J, Gottlieb J. Video Consultation During the COVID-19 Pandemic: A Single Center's Experience with Lung Transplant Recipients. Telemed J E Health 2021;27:807-15. [PMID: 33054671 DOI: 10.1089/tmj.2020.0170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
80 de Degani GL, Duarte L, Ismael J, Martinez L, López F. The impact of the COVID-19 pandemic on cancer care in the public health subsector, province of Santa Fe, Argentina. Ecancermedicalscience 2021;15:1270. [PMID: 34567255 DOI: 10.3332/ecancer.2021.1270] [Reference Citation Analysis]
81 Kushner T, Cafardi J. Chronic Liver Disease and COVID-19: Alcohol Use Disorder/Alcohol-Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis. Clin Liver Dis (Hoboken). 2020;15:195-199. [PMID: 32537135 DOI: 10.1002/cld.974] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
82 Inchingolo R, Acquafredda F, Tedeschi M, Laera L, Surico G, Surgo A, Fiorentino A, Spiliopoulos S, de’Angelis N, Memeo R. Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic. World J Gastroenterol 2021; 27(25): 3780-3789 [PMID: 34321843 DOI: 10.3748/wjg.v27.i25.3780] [Reference Citation Analysis]
83 Cholankeril G, Goli K, Rana A, Hernaez R, Podboy A, Jalal P, Da BL, Satapathy SK, Kim D, Ahmed A, Goss J, Kanwal F. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology 2021;74:3316-29. [PMID: 34310738 DOI: 10.1002/hep.32067] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
84 Sperring H, Ruiz-Mercado G, Schechter-Perkins EM. Impact of the 2020 COVID-19 Pandemic on Ambulatory Hepatitis C Testing. J Prim Care Community Health. 2020;11:2150132720969554. [PMID: 33225792 DOI: 10.1177/2150132720969554] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]